We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bone Therapeutics Sa | LSE:0R55 | London | Ordinary Share | BE0974280126 | BONE THERAPEUTICS ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 3.845 | 3.75 | 3.94 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1,343 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 316k | -2.04M | -0.0168 | -1.19 | 2.44M |
Date | Time | Source | Headline |
---|---|---|---|
20/3/2024 | 06:00 | UKREG | BioSenic presents successful preclinical data on its ATO medication for.. |
20/3/2024 | 06:00 | UKREG | BioSenic présente des données précliniques concluantes sur son médicament.. |
12/3/2024 | 06:00 | UKREG | BioSenic releases details of optimized administration approach ahead of.. |
12/3/2024 | 06:00 | UKREG | BioSenic publie les détails de la stratégie d'administration optimisée pour.. |
29/2/2024 | 06:00 | UKREG | BioSenic S.A. : Information on the total number of voting rights and.. |
29/2/2024 | 06:00 | UKREG | BioSenic S.A. : Information relative au nombre total de droits de vote et.. |
02/2/2024 | 16:30 | UKREG | BioSenic raises €500,000 in private placement of new shares with.. |
02/2/2024 | 16:30 | UKREG | BioSenic lève 500 000 euros dans le cadre d'un placement privé d'actions.. |
31/1/2024 | 09:30 | UKREG | BioSenic soutient la prochaine conférence européenne sur la maladie du.. |
31/1/2024 | 09:30 | UKREG | BioSenic provides support to forthcoming European conference on.. |
1 Year Bone Therapeutics Chart |
Intraday Bone Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions